LIFECORE BIOMEDICAL, INC.

Join this Action
Practice Area:
Stock Symbol: LFCR
Case Status: Recent Cases

Ademi LLP is investigating whether the proposed acquisition of Lifecore (Nasdaq: LFCR) by Webster Equity Partners, provides fair value to Lifecore’s public shareholders and whether Lifecore’s Board adequately protected shareholder interests in negotiating and approving the transaction.

What Is Ademi LLP Investigating?

  • The exchange ratio and whether it adequately reflects Lifecore’s value and future prospects;
  • Substantial change-of-control benefits available to Lifecore insiders in connection with the transaction;
  • Restrictions on competing transactions, including a significant termination penalty that may discourage another potential buyer from making a superior proposal; and
  • The conduct of Lifecore’s Board of Directors in negotiating and approving the transaction and whether the Board fulfilled its duties to public shareholders.

 

Join this Action